{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:58:28Z","timestamp":1765486708424},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,22]]},"DOI":"10.7759\/cureus.20593","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T08:40:54Z","timestamp":1640162454000},"source":"Crossref","is-referenced-by-count":6,"title":["Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center"],"prefix":"10.7759","author":[{"given":"Yara E","family":"Aljefri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana A","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakan  S","family":"Alajmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taif A","family":"Alkhamisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel A","family":"Maaddawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A","family":"Alraddadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awadh M","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel S","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018, 182:27-36. 10.1016\/j.jsbmb.2018.04.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic DA","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015, 36:487-525. 10.1210\/er.2015-1018","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-4-811","article-title":"Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease","volume":"73","author":"Fauser BC","year":"1991","unstructured":"Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab. 1991, 73:811-7. 10.1210\/jcem-73-4-811","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2017.09.08","article-title":"Dermatologic manifestations of endocrine disorders","volume":"6","author":"Lause M","year":"2017","unstructured":"Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017, 6:300-12. 10.21037\/tp.2017.09.08","journal-title":"Transl Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/14647273.2011.632058","article-title":"Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity","volume":"14","author":"Sivayoganathan D","year":"2011","unstructured":"Sivayoganathan D, Maruthini D, Glanville JM, Balen AH. Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity. Hum Fertil (Camb). 2011, 14:261-5. 10.3109\/14647273.2011.632058","journal-title":"Hum Fertil (Camb)"},{"key":"ref6","article-title":"Polycystic ovary syndrome and acne","volume":"15","author":"Chuan SS","year":"2010","unstructured":"Chuan SS, Chang RJ. Polycystic ovary syndrome and acne. Skin Therapy Lett. 2010, 15:1-4.","journal-title":"Skin Therapy Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962011000100015","article-title":"Polycystic ovary syndrome: a dermatologic approach","volume":"86","author":"Moura HH","year":"2011","unstructured":"Moura HH, Costa DL, Bagatin E, Sodr\u00e9 CT, Manela-Azulay M. Polycystic ovary syndrome: a dermatologic approach. An Bras Dermatol. 2011, 86:111-9. 10.1590\/s0365-05962011000100015","journal-title":"An Bras Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng X","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020, 502:214-21. 10.1016\/j.cca.2019.11.003","journal-title":"Clin Chim Acta"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney LG","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017, 32:1075-91. 10.1093\/humrep\/dex044","journal-title":"Hum Reprod"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.202275","article-title":"Cutaneous manifestations of polycystic ovary syndrome: a cross-sectional clinical study","volume":"8","author":"Keen MA","year":"2017","unstructured":"Keen MA, Shah IH, Sheikh G. Cutaneous manifestations of polycystic ovary syndrome: a cross-sectional clinical study. Indian Dermatol Online J. 2017, 8:104-10. 10.4103\/2229-5178.202275","journal-title":"Indian Dermatol Online J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.160505","article-title":"Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: a cross-sectional study clinical study","volume":"60","author":"Gowri BV","year":"2015","unstructured":"Gowri BV, Chandravathi PL, Sindhu PS, Naidu KS. Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: a cross-sectional study clinical study. Indian J Dermatol. 2015, 60:419. 10.4103\/0019-5154.160505","journal-title":"Indian J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20201235","article-title":"Study of cutaneous manifestations of polycystic ovarian syndrome","volume":"9","author":"Kaur S","year":"2020","unstructured":"Kaur S, Gupta S, Juneja S, et al.. Study of cutaneous manifestations of polycystic ovarian syndrome. Int J Reprod Contracept Obstet Gynecol. 2020, 9:1627-31. 10.18203\/2320-1770.ijrcog20201235","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/1658-631X.112920","article-title":"Hormonal, metabolic and clinical profile of Saudi women with polycystic ovary syndrome","volume":"1","author":"Al-Mulhim AA","year":"2013","unstructured":"Al-Mulhim AA, Abul-Heija AA, Al-Talib AA, et al.. Hormonal, metabolic and clinical profile of Saudi women with polycystic ovary syndrome. Saudi J Med Med Sci. 2013, 1:30-4. 10.4103\/1658-631X.112920","journal-title":"Saudi J Med Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmau.2013.06.002","article-title":"Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females","volume":"1","author":"Guraya SS","year":"2013","unstructured":"Guraya SS. Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females. J Microsc Ultrastruct. 2013, 1:30-4. 10.1016\/j.jmau.2013.06.002","journal-title":"J Microsc Ultrastruct"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12816\/0036667","article-title":"Clinical presentation of polycystic ovary syndrome among Saudi Arabian women-Jeddah-Saudi Arabia","volume":"67","author":"Alsibyani NA","year":"2018","unstructured":"Alsibyani NA, Malibary MA, Derham AA, et al.. Clinical presentation of polycystic ovary syndrome among Saudi Arabian women-Jeddah-Saudi Arabia. J Hosp Med. 2018, 67:494-8. 10.12816\/0036667","journal-title":"J Hosp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.05.086","article-title":"Risk of psychological burden in polycystic ovary syndrome: a case control study in Riyadh, Saudi Arabia","volume":"274","author":"Asdaq SM","year":"2020","unstructured":"Asdaq SM, Yasmin F. Risk of psychological burden in polycystic ovary syndrome: a case control study in Riyadh, Saudi Arabia. J Affect Disord. 2020, 274:205-9. 10.1016\/j.jad.2020.05.086","journal-title":"J Affect Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12432","article-title":"Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients","volume":"29","author":"Hong JS","year":"2015","unstructured":"Hong JS, Kwon HH, Park SY, et al.. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients. J Eur Acad Dermatol Venereol. 2015, 29:42-7. 10.1111\/jdv.12432","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/00016340903353284","article-title":"Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism","volume":"89","author":"Ozdemir S","year":"2010","unstructured":"Ozdemir S, Ozdemir M, G\u00f6rkemli H, Kiyici A, Bodur S. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010, 89:199-204. 10.3109\/00016340903353284","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.4498","article-title":"Cutaneous findings and systemic associations in women with polycystic ovary syndrome","volume":"152","author":"Schmidt TH","year":"2016","unstructured":"Schmidt TH, Khanijow K, Cedars MI, et al.. Cutaneous findings and systemic associations in women with polycystic ovary syndrome. JAMA Dermatol. 2016, 152:391-8. 10.1001\/jamadermatol.2015.4498","journal-title":"JAMA Dermatol"},{"key":"ref20","article-title":"Association between isolated female acne and insulin resistance: a prospective study","volume":"151","author":"Kartal D","year":"2016","unstructured":"Kartal D, Yildiz H, Ertas R, Borlu M, Utas S. Association between isolated female acne and insulin resistance: a prospective study. G Ital Dermatol Venereol. 2016, 151:353-7.","journal-title":"G Ital Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2021.8799","article-title":"Cutaneous manifestation of polycystic ovary syndrome","volume":"13","author":"Abusailik MA","year":"2021","unstructured":"Abusailik MA, Muhanna AM, Almuhisen AA, Alhasanat AM, Alshamaseen AM, Mustafa SMB, Nawaiseh MB. Cutaneous manifestation of polycystic ovary syndrome. Dermatol Reports. 2021, 13:8799. 10.4081\/dr.2021.8799","journal-title":"Dermatol Reports"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02548","article-title":"Female pattern hair loss and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee","volume":"104","author":"Carmina E","year":"2019","unstructured":"Carmina E, Azziz R, Bergfeld W, et al.. Female pattern hair loss and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019, 104:2875-91. 10.1210\/jc.2018-02548","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2019.06.030","article-title":"Skin disease related to metabolic syndrome in women","volume":"5","author":"Misitzis A","year":"2019","unstructured":"Misitzis A, Cunha PR, Kroumpouzos G. Skin disease related to metabolic syndrome in women. Int J Womens Dermatol. 2019, 5:205-12. 10.1016\/j.ijwd.2019.06.030","journal-title":"Int J Womens Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1062864","article-title":"Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome","volume":"31","author":"Trummer C","year":"2015","unstructured":"Trummer C, Schwetz V, Giuliani A, Obermayer-Pietsch B, Lerchbaum E. Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome. Gynecol Endocrinol. 2015, 31:819-23. 10.3109\/09513590.2015.1062864","journal-title":"Gynecol Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00263","article-title":"The association between prolactin and metabolic parameters in PCOS women: a retrospective analysis","volume":"11","author":"Yang H","year":"2020","unstructured":"Yang H, Di J, Pan J, Yu R, Teng Y, Cai Z, Deng X. The association between prolactin and metabolic parameters in PCOS women: a retrospective analysis. Front Endocrinol (Lausanne). 2020, 11:263. 10.3389\/fendo.2020.00263","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref26","article-title":"Prolactin secretion in polycystic ovary syndrome (PCOS)","volume":"36","author":"Szosland K","year":"2015","unstructured":"Szosland K, Pawlowicz P, Lewi\u0144ski A. Prolactin secretion in polycystic ovary syndrome (PCOS). Neuro Endocrinol Lett. 2015, 36:53-8.","journal-title":"Neuro Endocrinol Lett"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108263","article-title":"Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype","volume":"9","author":"Lerchbaum E","year":"2014","unstructured":"Lerchbaum E, Schwetz V, Rabe T, Giuliani A, Obermayer-Pietsch B. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype. PLoS One. 2014, 9:e108263. 10.1371\/journal.pone.0108263","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2007.01.005","article-title":"Clinical and metabolic features of polycystic ovary syndrome","volume":"97","author":"Li L","year":"2007","unstructured":"Li L, Yang D, Chen X, Chen Y, Feng S, Wang L. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet. 2007, 97:129-34. 10.1016\/j.ijgo.2007.01.005","journal-title":"Int J Gynaecol Obstet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13843","article-title":"Gender-specific risk factors for androgenetic alopecia in the Korean general population: associations with medical comorbidities and general health behaviors","volume":"57","author":"Kim BK","year":"2018","unstructured":"Kim BK, Choe SJ, Chung HC, Oh SS, Lee WS. Gender-specific risk factors for androgenetic alopecia in the Korean general population: associations with medical comorbidities and general health behaviors. Int J Dermatol. 2018, 57:183-92. 10.1111\/ijd.13843","journal-title":"Int J Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot PC","year":"2011","unstructured":"de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011, 17:495-500. 10.1093\/humupd\/dmr001","journal-title":"Hum Reprod Update"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann DA","year":"2006","unstructured":"Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91:48-53. 10.1210\/jc.2005-1329","journal-title":"J Clin Endocrinol Metab"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/IJPSYM.IJPSYM_561_17","article-title":"Anxiety, depression, and quality of life in women with polycystic ovarian syndrome","volume":"40","author":"Chaudhari AP","year":"2018","unstructured":"Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018, 40:239-46. 10.4103\/IJPSYM.IJPSYM_561_17","journal-title":"Indian J Psychol Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00138-2017","article-title":"Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study","volume":"4","author":"Zierau L","year":"2018","unstructured":"Zierau L, Cortes R, Thomsen SF, Jimenez-Solem E, Lindenberg S, Backer V. Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study. ERJ Open Res. 2018, 4:00138-2017. 10.1183\/23120541.00138-2017","journal-title":"ERJ Open Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.08.025","article-title":"Coexistence of asthma and polycystic ovary syndrome: a concise review","volume":"119","author":"Zierau L","year":"2016","unstructured":"Zierau L, Gade EJ, Lindenberg S, Backer V, Thomsen SF. Coexistence of asthma and polycystic ovary syndrome: a concise review. Respir Med. 2016, 119:155-9. 10.1016\/j.rmed.2016.08.025","journal-title":"Respir Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79142-cutaneous-manifestations-and-hormonal-changes-among-polycystic-ovary-syndrome-patients-at-a-tertiary-care-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:50Z","timestamp":1707507290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79142-cutaneous-manifestations-and-hormonal-changes-among-polycystic-ovary-syndrome-patients-at-a-tertiary-care-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.20593","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,22]]}}}